IL2 and myasthenia gravis: Chien et al. confirmed Glucosamine could reduce IL2 downstream signaling through downregulating IL2RA [36], while IL2 and IL2RA (CD25) were upregulated in patients with MG, and IL2RA might affect the clinical symptoms of MG [37,38].